Biology of von Willebrand factor;Biologie du facteur Willebrand

Nephrologie et Therapeutique

Volumn 2, Issue SUPPL. 2, 2006, Pages

  Girma, Jean Pierre ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

ADAMTS13; Thrombotic thrombocytopenic purpura; Von Willebrand factor

Indexed keywords

GLYCOPROTEIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTERY OCCLUSION; CONFERENCE PAPER; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; HYDROPHOBICITY; MEGAKARYOCYTE; MICROCIRCULATION; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SHEAR RATE; SUBENDOTHELIUM; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

BLOOD COAGULATION; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HUMANS; MEGAKARYOCYTES; PLATELET ADHESIVENESS; PLATELET AGGREGATION; VON WILLEBRAND FACTOR;

EID: 31544479075     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003;1:1335-42.
2. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001;14:257-79.
3. Chopek MW, Girma JP, Fujikawa K, Davie EW, Titani K. Human von Willebrand Factor: a multivalent protein composed of identical subunits. Biochemistry 1986;25:3146-55.
4. Nogami K, Shima M, Nishiya K, Hosokawa K, Saenko EL, Sakurai Y et al. A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation. Blood 2002;99:3993-8.
5. Siedlecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;88:2939-50.
6. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991;87:1234-40.
7. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein-IIb-IIIa (integrin-alpha(IIb) beta(3) mediated by fibrinogen and glycoprotein-Ib-von Willebrand factor. J Biol Chem 1992;267:11300-6.
8. Roest M, Sixma JJ, Wu YP, Ijsseldijk MJW, Tempelman M, Slootweg PJ, et al. Platelet adhesion to collagen in healthy volunteers is influenced by variation of both alpha(2)beta(1) density and von Willebrand factor. Blood 2000;96:1433-7.
9. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002;100:4033-9.
10. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-34.
11. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996;87:4235-44.
12. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990;87:6306-10.
13. Sadler JE. A new name in thrombosis, ADAMTS13. Proc Natl Acad Sci USA 2002;99:11552-4.
14. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
15. Tsai HM, Lian ECY. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
16. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-94.
17. Zheng XL, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001;276:41059-63.
18. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001;98:1654-61.
19. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001;98:1662-6.
20. Soejima K, Mimura N, Hirashima M, Maeda H, Hamamoto T, Nakagaki T, et at. A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease? J Biochem 2001;130:475-80.
21. Zhou W, Inada M, Lee TP, Benten D, Lyubsky S, Bouhassira EE, et al. ADAMTS13 is expressed in hepatic stellate cells. Lab Invest 2005.
22. Zheng X, Nishio K, Majerus EM, Sadler JE. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. J Biol Chem 2003;278:30136-41.
23. Soejima K, Matsumoto M, Kokame K, Yagi H, Ishizashi H, Maeda H, et al. ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood 2003;102:3232-7.
24. Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to von Willebrand factor. J Biol Chem papers in press. Published on April 11, 2005.
25. Tao Z, Wang Y, Choi H, Bernardo A, Nishio K, Sadler JE, et al. Cleavage of ultra-large multimers of Von Willebrand factor by C-terminal truncated mutants of ADAMTS-13 under flow. Blood first edition paper, prepublished online March 17, 2005.
26. Meyer D, Fressinaud E, Hilbert L, Ribba AS, Lavergne JM, Mazurier C. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Best Pract Res Clin Haematol 2001;14:349-64.
27. Levy GG, Motto DG, Ginsburg D. ADAMTS13 Turns 3. Blood first edition paper, prepublished online March 17, 2005.